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A simulation study on the use of
response-adaptive randomized designs
Uno studio di simulazione sull’uso di disegni casuali
adattivi alla risposta
Anna Maria Paganoni, Andrea Ghiglietti, Maria Giovanna Scarale, Rosalba Miceli,
Francesca Ieva, Luigi Mariani, Cecilia Gavazzi and Valeria Edefonti
Abstract Response-adaptive designs have been proposed in randomized clinical tri-
als to achieve ethical advantages by using sequential accrual information collected
during the trial to update probabilities of treatment assignments. We propose the
use of a response adaptive design based on urn models in a simulation study on a
randomized clinical trial on the efficacy of home enteral nutrition in cancer patients
after major gastrointestinal surgery. We compare results with the adaptive design
with those previously obtained with the non-adaptive approach.
Abstract I disegni adattivi alla risposta sono stati proposti nell’ambito degli studi
clinici per ottenere vantaggi etici utilizzando le informazioni sequenziali raccolte
durante lo studio per aggiornare le probabilita` di assegnazione ai trattamenti. In
questo lavoro si propone l’uso di un disegno adattivo di risposta basato su modelli
d’urna in uno studio di simulazione basato su uno studio clinico dell’efficacia della
nutrizione enterale domiciliare in pazienti oncologici dopo un intervento chirurgico
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gastrointestinale maggiore. Si confrontano i risultati del disegno adattivo con quelli
precedentemente ottenuti con l’approccio non adattivo.
Keywords: Randomly Reinforced Urn model, Randomized trials, Response-adaptive
randomization, Simulation study
1 Introduction
In statistical literature, urn models have been widely studied as mathematical tools
to implement randomization in the context of clinical trials. These designs randomly
assign those subjects that sequentially enter the trial to the treatment arms according
to to the proportion of balls of different color sampled from a virtual urn. Recently,
interest has been increased in the use of urn models, in which the probability to sam-
ple a ball of a certain type depends on the treatment performance observed on the
subjects previously randomized [2, 1]. A popular class of such designs is the Ran-
domly Reinforced Urn (RRU) model, which has been introduced in [2] for binary
treatment responses and extended in [5] to handle continuous responses. In the RRU
model, an urn containing balls of two colors is sequentially sampled and the sub-
jects in the trial receive the treatments associated to the colors of the sampled balls.
In addition, the urn composition is sequentially updated by adding new balls of the
same color of the sampled ones, whose number depend each time on the response
observed by the correspondent patient. For the purposes of this paper, we simply
remind that a RRU design assigns patients to the superior treatment with a proba-
bility that converges to one as the sample size increases. Although the theoretical
result of assigning most of the patients to the superior treatment is very attractive
from the ethical point of view, the RRU design have rarely been implemented in
clinical trials or in simulation studies based on a real set-up. In detail, we will sim-
ulate a large number of trials that follow the RRU model starting from the real-life
data collected in a previously published Home Enteral Nutrition (HEN) randomized
trial [3], where a non-adaptive design was originally adopted (see [4]). Comparing
the performance of the RRU with that of the original non-adaptive design, we ex-
pect that the RRU design will: 1) assign fewer patients to the inferior treatment; 2)
maintain similar inferential properties. This will turn out in an advantage in terms
of both statistical performance and ethical responsibility.
2 Materials and Methods
The RRU model was here implemented in a simulation study based on results from
a multicenter, controlled, open-label, two-parallel groups, randomized clinical trial
conducted at the Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan,
Italy, and at the European Institute of Oncology, Milan, Italy, between December
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2008 and June 2011 [3]. The enrolled subjects were adult (> 18 years) patients with
documented upper gastrointestinal cancer who were candidates for major elective
surgery and showed a preoperative nutritional risk score that indicated a potential
benefit from any nutritional intervention. A random permuted block design (strati-
fied for referring center) randomly assigned patients before discharge to receive ei-
ther HEN to cover the basal energy requirement (experimental group), or nutritional
counselling by an expert dietitian, including oral supplements only when needed
(Control Group - CG), in a 1:1 ratio. The treatment effect was defined as the dif-
ference between the mean “weight change” (weight after two months - weight at
baseline) in the HEN and nutritional counselling arms (primary end-point). In to-
tal, 79 patients were initially randomized; however, as 11 patients had a missing
two-months weight, the final analysis was performed on 68 patients, of which 33
patients were allocated to the HEN group and 35 to the CG. The main result of the
primary end-point analysis was that the mean weight loss in the patients undertak-
ing the HEN treatment was significantly lower than that in the CG, with a treatment
effect estimated by the corresponding ANOVA model coefficient (95% confidence
interval) of 3.2 (1.1-5.3) and a p-value from the corresponding two-sided t-test equal
to 0.31%< 2.94%. For this reason, the trial was stopped at the interim analysis and
results from this analysis were published in [3]. So, the HEN was found to be the
superior treatment in this trial.
To simulate the RRU design starting from the HEN trial data to derive the re-
sults for comparing the RRU design with the non-adaptive one, we performed the
following main steps:
(A)using the HEN trial dataset [3]:
(1)we estimated the parameters of the Gaussian distribution of the responses to
the HEN group;
(2)we estimated the parameters of the Gaussian distribution of the responses in
the CG;
(3)we computed the empirical distribution of the difference between arrival times
of consecutive subjects;
(B)we simulated N independent trial samples based on the RRU model; for each
sample, responses to both treatments and intervals between arrival times were
randomly generated from distributions introduced in point (A);
(C)we computed from these N trials:
(1)the empirical distribution of the number of subjects assigned to the inferior
treatment W ;
(2)the empirical power of the corresponding t-test.
The previous steps are detailed in the following.
To start, we considered three alternative set-ups of trial sample sizes equal to (a):
n = 58;(b): n = 68; (c): n = 78, where the total sample size 68 of the HEN trial
was used as the reference set-up and we moved ±15% from that to get other two
reasonable sample sizes.
For each set-up, we performed N = 10,000 simulations of independent trials based
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on the RRU design: in each run we have a virtual urn to be sampled and reinforced.
Formally, we denote by (Rji ,W
j
i ) the urn composition and by R
j
i /(R
j
i +W
j
i ) the urn
proportion in simulation j = {1, ..,N} at time i 2 {1, ..,n}.
All the urns start with the same (fixed) initial composition, i.e. (Rj0,W
j
0 ) = (R0,W0)
for any j= {1, ..,N}. Then, the urn composition (Rji ,W ji ) is updated in the following
way 8><>:
Rji = R
j
i 1+Âk2(Aji+1\Aji )
X jk x
j
Rk
W ji =W
j
i 1+Âk2(Aji+1\Aji )
(1 X jk )x jWk,
where X jk is a Bernoulli random variable with parameter R
j
k 1/(R
j
k 1+W
j
k 1) in-
dicating the treatment assignement, the set Aji here includes all the patients who
arrived two months earlier than subject i and x jRk, x
j
Wk are the subjects responses to
treatment R andW respectively. Indeed, in the HEN trial, responses were available
only two months after treatment administration.
In addition, as normality assumptions in the original data were not rejected, re-
sponses to both treatments were generated as independent Gaussian random vari-
ables with arm-specific means and variances computed using the HEN dataset and
given by: mR =  0.315 and sR = 3.868 for treatment R (HEN group), mW =
 3.571 and sW = 4.789 for treatment W (CG). Formally, we generated the fol-
lowing quantities:
(1)x jR1, ..,x
j
Rn ⇠N (mR,s2R) potential responses to treatmentR (HEN group);
(2)x jW1, ..,x
j
Wn ⇠N (mW ,s2W ) potential responses to treatment W (CG),
where either x jRi or x
j
Wi is observed, as each subject just receives one treatment.
3 Results
Table 1 shows some descriptive statistics of the empirical distribution of the number
of subjects assigned to the inferior treatment, NW (n), and the empirical power of the
t-test, 1  bˆ , for the different sample sizes n, in comparison with the corresponding
results for the non-adaptive design, nW and 1 b .
For all sample sizes under consideration [cases (a)-(b)-(c)], the mean and the me-
dian of NW (n) were smaller than nW , the number of subjects assigned to the inferior
treatment by the non-adaptive design. It follows that the RRU design provided 50%
of probability (or more) to assign fewer subjects to the inferior treatment, as com-
pared to the non-adaptive design. Although higher than nW for all the sample sizes
considered, the third quartile of NW (n) in the RRU design was very close to nW for
any n under consideration. In addition, the obtained values for the t-test empirical
power under the RRU design were close, but slightly smaller than, the correspond-
ing power values derived in the non-adaptive design.
Further information on the distribution of NW (n) is provided by the boxplots re-
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n NW (n) nW 1 b 1  bˆ
1st quartile Mean Median 3rd quartile
(a) 58 19 25.6 25 31 29 0.88 0.83
(b) 68 22 29.6 29 36 35 0.92 0.88
(c) 78 25 33.6 33 41 38 0.94 0.92
Table 1 Summary statistics (1st and 3rd quartiles, mean, and median) of the empirical distribution
of the number of subjects assigned to the inferior treatment, NW (n), and empirical power, 1  bˆ , of
the t-test for equal mean weight changes (corresponding to the treatment coefficient in the ANOVA
model) for the different sample sizes n in the Randomly Reinforced Urn design, in comparison with
the corresponding results for the non-adaptive design, nW and 1 b . We reported in bold typeface
the results obtained with the same sample size of the original Home Enteral Nutrition trial.
ported in Figure 1. For any sample size, the median of NW (n) was below the dashed
line indicating the number of subjects assigned to the inferior treatment by the non-
adaptive design. Similarly, we confirmed that, although higher, the third quartile was
closer than the median to the dashed line for the three cases under consideration. In
addition, the probability that NW (n) was less than nW was close to 75% for any
sample size under consideration. Finally, although mostly symmetric, the empirical
distributions of the number of subjects assigned to the inferior treatment showed a
high level of variability. This variability increases, as the total sample size increases.
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Fig. 1 Boxplots of the number of subjects assigned to the inferior treatment (Control Group) in
the three cases reported above each picture: (a) n = 58, (b) n = 68, (c) n = 78. The dashed line
indicated the number of subjects assigned to the control group in the non-adaptive trial in the three
cases.
